SCHEMBL30007230

SCHEMBL30007230

Cc1cnc2c(OC3CC3)cc(C(=O)NCC(O)(c3cc(C(C)(C)O)c(F)c(-c4ccc(F)c(F)c4)n3)C3CC3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 4/20 0.36
AR P10275 1/20 0.33
CNR1 P21554 1/20 0.33
CYP2C9 P11712 2/20 0.32
MAPK14 Q16539 2/20 0.32
EPHX2 P34913 1/20 0.31
CTSA P10619 1/20 0.31
ENPP2 Q13822 2/20 0.30
BUB1 O43683 1/20 0.30
PRKACG P22612 1/20 0.30
MAPKAPK2 P49137 1/20 0.30
MAPK11 Q15759 1/20 0.30
ACSL5 Q9ULC5 1/20 0.30
STK24 Q9Y6E0 1/20 0.30
BCL9 O00512 1/20 0.30
CTNNB1 P35222 1/20 0.30
SLC5A7 Q9GZV3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25686195 1.00 GABRA5 (0.36) GABRA5ARCNR1CYP2C9MAPK14
SCHEMBL23958645 1.00 GABRA5 (0.36) GABRA5ARCNR1CYP2C9MAPK14
SCHEMBL25687289 0.93 CFTR (0.33) GABRA5ARCNR1CYP2C9MAPK14
SCHEMBL25242930 0.93 GABRA5 (0.37) GABRA5CNR1CYP2C9MAPK14CTSA
SCHEMBL30006951 0.93 CFTR (0.33) GABRA5ARCNR1CYP2C9MAPK14
SCHEMBL25232424 0.93 CFTR (0.33) GABRA5ARCNR1CYP2C9MAPK14
SCHEMBL30007933 0.93 GABRA5 (0.37) GABRA5CNR1CYP2C9MAPK14CTSA
SCHEMBL25687233 0.93 GABRA5 (0.37) GABRA5CNR1CYP2C9MAPK14CTSA
SCHEMBL23958649 0.91 POLB (0.34) CNR1CYP2C9MAPK14EPHX2ENPP2
SCHEMBL30007202 0.91 POLB (0.34) CNR1CYP2C9MAPK14EPHX2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115461336-A RSV inhibiting 3-substituted quinoline and cinnoline derivatives 爱尔兰詹森科学公司 2022-12-09 CN disclosed